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Nephrotoxicity is a frequent complication of cisplatin-based
chemotherapy often limiting its use. In this study, we
attempted to the role of the phosphoinositide-3 kinase
(PI3K)-c–Akt pathway in this form of acute kidney injury.
Using PI3K-c knockout mice, we found that a conventional
dose of cisplatin was more lethal in the knockout mice
where the blood urea nitrogen and serum creatinine were
significantly higher in them than in wild-type mice.
Phosphorylation of Akt in the renal tubules was abrogated
in the knockout mice with the severity of renal dysfunction
and numbers of TUNEL (terminal deoxynucleotidyl
transferase (TdT) mediated nick-end labeling)-positive renal
tubule cells being higher in the knockout than in wild-type
mice. Cisplatin treatment significantly increased. Caspase-3
activity, histone-associated DNA fragments, and number
of annexin V-positive cells was significantly higher in
cisplatin-treated primary cultured renal tubular epithelial
cells of knockout mice. Transfection of dominant-active
forms of Akt and PI3K-c ameliorated apoptosis of the
tubule epithelial cells derived from the knockout mice.
Our results suggest that the PI3K-c–Akt pathway lessens
apoptosis and plays a critical role in the maintenance of
renal function in cisplatin-induced acute kidney injury.
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Cisplatin is one of the most effective and potent anticancer
drugs in the treatment of epithelial malignancies such as
lung, head and neck, ovarian, bladder, and testicular cancers.1
The major constraint to cisplatin-based chemotherapy is
frequent nephrotoxicity.2 The antineoplastic effect of cispla-
tin is dose dependent; yet, the risk of nephrotoxicity often
precludes the use of higher doses to maximize the therapeutic
effect. The mechanisms behind the acute renal injury (AKI)
following cisplatin exposure include direct tubular toxicity
in the form of apoptosis and necrosis,2,3 vascular factors,4,5
and inflammation.6,7 Recent studies suggest that a cisplatin
injury, much like ischemia–reperfusion, can cause cell dys-
function and neutrophil infiltration and subsequent release of
cytokines/chemokines.8–10 The infiltration of circulating leuko-
cytes, meanwhile, is reported to be triggered by locally secre-
ted cytokines/chemokines such as tumor necrosis factor-a
(TNF-a) and intercellular adhesion molecule (ICAM)-1.6,7,10
Cisplatin induces apoptosis of renal proximal tubule
cells (LLC-PK1) in vitro via mitochondria-dependent and
-independent pathways,11 partly through the activation
of caspase-3.12 Oxidant stress also appears to contribute to
the cisplatin-induced apoptosis of renal tubular cells, both
in vitro and in vivo.13 Recent studies suggest that caspase
inhibitors attenuate ischemia-induced AKI in rats.14 The
pathophysiological roles of apoptosis in cisplatin-induced
AKI, however, are not well clarified.
Growing evidence suggests that the serine–threonine
kinase Akt/protein kinase B protects cells from apoptosis
as a critical enzyme in the cell survival pathway.15–18 Class I
PI3Ks are dual-specific lipid protein kinases involved in
numerous intracellular signaling pathways. Class IA includes
three catalytic subunits (p110a (encoded by Pi3kca), p110b
(encoded by Pi3kcb), and p110d (encoded by Pi3kcd)) known
to be activated through tyrosine kinase signaling and to form
a complex with regulatory SH2 (Src homology 2 domain)-
containing p85 subunits.19 Class IB p110g is mainly activated
by seven-transmembrane G-protein-coupled receptors.
PI3Ka/ and PI3Kb/ mice often die during the early
stages of embryonic development,20,21 whereas mice lacking
PI3Kg expression show no overt adverse phenotype.22,23 PI3K
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signaling pathways phosphorylate and activate Akt, thereby
eliciting many physiological functions and responses.16,17
Cellular stresses such as heat shock and oxidative stress have
been reported to stimulate the PI3K and Akt pathways.24–26
Akt activates the prosurvival transcription factor nuclear
factor-kB and inhibits apoptosis after the release of cyto-
chrome c by phosphorylating and inhibiting caspase-9.27,28
Much less is known, however, of the functional roles
of the PI3Kg–Akt pathway in cisplatin-induced AKI.
In this study, we investigated the roles of the Akt pathway
and apoptotic signals in cisplatin-induced AKI in vivo using
PI3Kg-knockout mice, homozygotes for a gene-targeted dele-
tion of the PI3Kg gene. These mice had been well characterized
before the outset of this study and no abnormalities had been
reported in either their renal function or histology.22,23
The study was conducted to test whether the PI3Kg–Akt
pathway plays a key role in the regulation of renal tubular cell
death or affects the course of cisplatin-induced AKI. To
achieve this, we examined differences in the renal function,
histology, and tubular cell death in cisplatin-induced
AKI between PI3Kgþ /þ and PI3Kg/ mice. Our
data demonstrate that the PI3Kg–Akt pathway is activated
and mediates renal tubular injury in cisplatin-induced AKI
and that blockage of the PI3Kg–Akt pathway worsens the
prognosis by accelerating renal tubular cell death.
RESULTS
Disruption of PI3Kc leads to increased lethality during
conventional dose of cisplatin treatment
Our first step was to examine the renal function of PI3Kgþ /þ
and PI3Kg/ mice using a conventional cisplatin dose
(20 mg kg1).6,29 Only 16% of the PI3Kg/ mice survived
at 5 days after the cisplatin injection at this dose. In contrast,
88% of the PI3Kþ /þ mice survived at the same time point
(Figure 1b). At the higher dose of 30 mg kg1, 100% of the
PI3Kg/ mice died within 5 days, whereas only 48% of the
PI3Kgþ /þ mice died during the same period (Figure 1c).
At the lower dose of 15 mg kg1, 56% of the PI3Kg/ mice
died within 5 days, whereas only 4% of the PI3Kgþ /þ mice
died during the same period (Figure 1a). No deaths were
observed in sham-injected (saline 1 ml) mice of either
genotype.
Time course of blood urea nitrogen and serum creatinine in
PI3Kcþ /þ and PI3Kc/ mice receiving low-dose cisplatin
The low-dose (15 mg kg1) cisplatin led to mild renal
dysfunction in the PI3Kgþ /þ mice, increasing blood urea
nitrogen (BUN) levels from 19.7±0.8 mg per 100 ml before
the injection to 79.6±19.8 mg per 100 ml at 3 days after the
injection (Figure 2a). The BUN level in PI3Kg/ mice
treated with the same cisplatin dose increased as high as
167.3±31.2 mg per 100 ml at 3 days after the injection,
confirming that PI3Kg deficiency significantly exacerbated
the cisplatin-induced renal dysfunction. The serum creatinine
level also increased in PI3Kgþ /þ mice, edging upward
from 0.23±0.11 mg per 100 ml before the cisplatin injection
to 1.45±0.45 mg per 100 ml at 3 days after the injection
(Figure 2b). The serum creatinine level in PI3Kg/
mice treated with the same dose of cisplatin rose from
0.22±0.12 mg per 100 ml before the injection to 2.68±0.61 mg
per 100 ml at 3 days after the injection, again indicating that
PI3Kg deficiency significantly exacerbated the cisplatin-
induced renal dysfunction (Figure 2b).
Histological examination and leukocyte infiltration in
PI3Kcþ /þ and PI3Kc/ mice
Impairment of renal function, as assessed by BUN and serum
creatinine levels, was corroborated by histological evidence.
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Figure 1 | Survival curves of PI3Kcþ /þ and PI3Kc/ mice after the cisplatin administration. (a) A low dose of cisplatin (15 mg kg1)
was injected to PI3Kgþ /þ mice (K) and PI3Kg/ mice (’) intraperitoneally (N¼ 25, each group). (b) A conventional cisplatin dose
(20 mg kg1) was injected to PI3Kgþ /þ mice (K) and PI3Kg/ mice (’) intraperitoneally (N¼ 25, each group). (c) A higher dose of cisplatin
(30 mg kg1) was injected to PI3Kgþ /þ mice (K) and PI3Kg/ mice (’) intraperitoneally (N¼ 25, each group). Statistically significant
differences (*Po0.05) are indicated at 5 days.
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Examination of the kidneys of PI3Kgþ /þ mice at 72 h after
the low-dose cisplatin (15 mg kg1) injection revealed a very
slight loss of tubular epithelial cells (TECs) and very little
intratubular debris or cast formation (Figure 3a and c).
Histological sections of the kidneys of PI3Kg/ mice had
significantly more tubular necrosis and degradation than
those of PI3Kgþ /þ mice in the cortex and outer medulla
(Figure 3b and d). The most severe morphologic changes
occurred in the proximal tubules of the outer medulla (Figure
3d). When hematoxylin and eosin-stained kidney tissues
were scored to determine the severity of the tubular injury,
the scores of PI3Kg/ mice were significantly higher than
those of PI3Kgþ /þ mice (Figure 3e, *Po0.05). Leukocyte
infiltration was measured by naphthol AS-D chloroacetate
esterase staining. As shown in Figure 3f, the cisplatin
injection led to an increase in leukocytes within the kidney
cortices of both PI3Kgþ /þ and PI3Kg/ mice. The
increments were larger in PI3Kg/ than in PI3Kgþ /þ
mice (Figure 3f, *Po0.05).
PI3Kc/ mice with cisplatin-induced AKI exhibit high TEC
death
Previous reports have suggested that the PI3K–Akt pathway
protects many cells from cell death signals. For further
insight, we used TUNEL (terminal deoxynucleotidyl trans-
ferase (TdT) mediated nick-end labeling) staining to assess
the amount of tubular cell death associated with cisplatin
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Figure 2 | Blood urea nitrogen (BUN) and serum creatinine (Cre)
levels in PI3Kcþ /þ and PI3Kc/ mice after the cisplatin
injection. A low dose of cisplatin (15 mg kg1) was injected to
PI3Kgþ /þ mice (white bar) and PI3Kg/ mice (black bar)
intraperitoneally (N¼ 28, each group). Blood was collected at
baseline (control) and at 2, 3, and 5 days after the cisplatin injection.
Blood urea nitrogen (a) and serum creatinine (b) were measured at
the indicated times. Data are mean±s.e.m. of seven mice per group.
Statistically significant differences (*Po0.05) are indicated.
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Figure 3 | Renal histopathology and scores for characteristic
histological signs of renal injury and leukocyte infiltration in
PI3Kcþ /þ and PI3Kc/ mice with cisplatin-induced acute
kidney injury. Kidneys were removed 72 h after injection with
cisplatin (15 mg kg1). (a) The kidneys of PI3Kgþ /þ mice treated
with a low dose (15 mg kg1) of cisplatin show a very slight loss of
tubular epithelial cells (TECs) and very low levels of intratubular debris
and cast formation at low-power magnification. Cort, cortex; OM,
outer medulla (original magnification  50). (b) The kidneys of
PI3Kg/ mice treated with a low dose (15 mg kg1) of cisplatin show
severe loss of TECs and severe tubular dilation, intratubular debris,
and cast formation at low-power magnification (original magnification
 50). (c) The kidneys of cisplatin-treated PI3Kgþ /þ mice show a
very slight loss of TECs and very little intratubular debris and cast
formation at high-power magnification (original magnification  400).
(d) The kidneys of cisplatin-treated PI3Kg/ mice show severe loss
of TECs and severe tubular dilation, intratubular debris, and cast
formation at high-power magnification (original magnification  400).
(e) The kidneys of PI3Kgþ /þ and PI3Kg/ mice manifest the
characteristic histological signs of renal injury. Tubular damage was
significantly higher in the kidneys of PI3Kg/ mice (black bars) than
in the kidneys of PI3Kgþ /þ mice (white bars). Data are mean±s.e.m.
of seven mice per group. Statistically significant differences (*Po0.05)
are indicated. (f) Leukocyte infiltration was measured by naphthol
AS-D chloroacetate esterase staining. The cisplatin injection (after
2 and 3 days) brought about an increase in leukocytes within the
kidney cortex in both PI3Kgþ /þ mice (white bars) and
PI3Kg/ mice (black bars). The increments were larger in
PI3Kg/ mice than in PI3Kgþ /þ mice (*Po0.05).
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(15 mg kg1)-induced AKI. Very few TUNEL-positive cells
were observed in PI3Kgþ /þ mice at 72 h after the low-dose
(15 mg kg1) cisplatin injection (Figure 4a). In contrast,
an abundance of TUNEL-positive cells was observed at the
same time point in the renal tubules of PI3Kg/ mice
receiving the same low-dose cisplatin injection (Figure 4b).
Notably, the number of TUNEL-positive cells was signifi-
cantly increased in PI3Kg/ mice (Figure 4c).
Profiles of TNF-a and ICAM-1 mRNA expression and protein
content in PI3Kcþ /þ and PI3Kc/ mice subjected to
cisplatin nephrotoxicity
TNF-a and ICAM-1 mRNA levels were measured by real-
time quantitative PCR, as described in the Materials and
Methods section. The mouse kidney tissues were harvested at
6, 12, and 24 h after a single injection of either saline (vehicle)
or cisplatin (15 mg kg1). The levels of TNF-a and ICAM-1
mRNA expression peaked at 12 h after the cisplatin injection
(data not shown).
As shown in Figure 5a and b, the real-time quantitative
PCR data and the band intensities of TNF-a and ICAM-1
PCR products in PI3Kgþ /þ mice were not significantly
different from those in PI3Kg/ mice. Next, we determined
TNFa and ICAM-1 levels in the kidney tissues of both
PI3Kgþ /þ and PI3Kg/ mice at 24 and 48 h, respectively,
after the cisplatin injection. PI3Kgþ /þ and PI3Kg/ mice
exhibited 11.7- and 12.5-fold increases in TNF-a protein
levels at 72 h after the cisplatin injection (Figure 5c), and 6.9-
and 7.8-fold increases in ICAM-1 protein levels at 48 h,
respectively, after the cisplatin injection (Figure 5d). There
were no significant differences in TNF-a or ICAM-1 levels
between PI3Kgþ /þ and PI3Kg/ mice after the cisplatin
administration.
Western blot analyses of phospho-Akt and phospho-Bad in
cisplatin-induced AKI
To determine the involvement of the Akt pathway in
cisplatin-induced AKI, we conducted western blot analyses
of phospho-specific Akt (Ser473) and total Akt in the renal
tissues of PI3Kgþ /þ and PI3Kg/ mice at 0, 24, 48, and
72 h after the induction of AKI by cisplatin injection. Strong
phosphorylation of Akt from the PI3Kgþ /þ mice was
observed from 24 h after the cisplatin injection and peaked at
48 h. In contrast, only a very weak band of phosphorylated
Akt was observed in the PI3Kg/ mice after the induction
of AKI by cisplatin injection (Figure 6a and b). The protein
levels of total Akt were not changed in association with the
cisplatin-induced AKI in either mouse group. The protein
level of total Akt did not differ between PI3Kgþ /þ and
PI3Kg/ mice (Figure 6a and b). Quantitative analyses
were performed to compare the level of phosphorylated Akt
with the level of total Akt in both PI3Kgþ /þ (white bar)
and PI3Kg/ mice (black bar) after the cisplatin admin-
istration (Figure 6c). The phosphorylation of Ser473 in the
Akt protein was significantly higher in PI3Kgþ /þ mice
than in PI3Kg/ mice at 24, 48, and 72 h after the cisplatin
administration. We next conducted western blot analyses of
phospho-specific Bad (Ser136) and total Bad in the renal
tissues of PI3Kgþ /þ and PI3Kg/ mice after the
induction of AKI by cisplatin injection. Strong phosphoryla-
tion of Bad from the PI3Kgþ /þ mice was observed from
24 h after the cisplatin injection and peaked at 48 h. In
contrast, only a very weak band of phosphorylated Bad was
observed in the PI3Kg/ mice after the induction of AKI
by cisplatin injection (Figure 6a and b). The protein levels of
total Bad were not changed in association with the cisplatin-
induced AKI in either mouse group. Quantitative analyses
were performed to compare the level of phosphorylated Bad
with the level of total Bad in both PI3Kgþ /þ (white bar)
and PI3Kg/ mice (black bar) after the cisplatin admin-
istration (Figure 6d). The phosphorylation of Ser136 in the
Bad protein was significantly higher in PI3Kgþ /þ mice
than in PI3Kg/ mice at 24 and 48 h after the cisplatin
administration. An immunoblot for actin prepared as a
loading marker revealed no significant changes in actin
during the cisplatin treatment.
Immunohistological examination of phosphorylated Akt in
cisplatin-induced AKI
Next, we used confocal microscopy to localize the Akt phos-
phorylation in cisplatin-induced AKI. As shown in Figure 7a,
phosphorylated Akt (Ser473) was faintly observed in the
renal tubules of the cortex and outer medulla in PI3Kgþ /þ
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Figure 4 | Tubular cell death in the renal tissues of PI3Kcþ /þ
and PI3Kc/ mice with cisplatin-induced acute kidney injury.
Kidneys were removed 72 h after an injection with the low dose of
cisplatin (15 mg kg1). (a) The kidneys of cisplatin-treated PI3Kgþ /þ
mice show very few TUNEL-positive cells (original magnification
 200). (b) The kidneys of cisplatin-treated PI3Kg/ mice show an
elevated number of TUNEL-positive renal tubular cells (original
magnification  200). (c) The number of TUNEL-positive tubular
cells was significantly higher in the kidneys of PI3Kg/ mice
(black bars) than in the kidneys of PI3Kgþ /þ mice (white bars).
Data are mean±s.e.m. of seven mice per group. Statistically
significant differences (*Po0.05) are indicated.
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mice (vehicle injected) at low-power magnification. The
staining of phosphorylated Akt was significantly enhanced
in the cortex and outer medulla at 48 h after the cisplatin
injection (Figure 7a and b). The staining was colocalized
with AQP1 (marker of proximal tubules). No staining
of phosphorylated Akt was observed in the inner medulla
of PI3Kgþ /þ mice, regardless of whether the animals were
injected with cisplatin or vehicle (Figure 7b). Staining of
phosphorylated Akt was absent in the cortex and outer
medulla of both the cisplatin- and vehicle-injected PI3Kg/
mice (Figure 8a and b). Staining of AQP1 was clearly
observed in the proximal tubules of PI3Kg/ mice. No
staining of phosphorylated Akt was observed in the inner
medulla of either cisplatin- or vehicle-injected PI3Kg/
mice (Figure 8b). Confocal microscopy at high-power
magnification revealed staining of phosphorylated Akt in
the cytoplasm of the proximal tubules of the outer medulla in
the cisplatin-injected PI3Kgþ /þ mice (Figure 9a). AQP1
was stained in the apical membrane of the same tubules.
Phosphorylated Akt was stained very weakly in the vehicle-
injected PI3Kgþ /þ mice (Figure 9a). Confocal microscopy
at high-power magnification revealed no staining of phos-
phorylated Akt in the cortical collecting ducts in the
cisplatin-injected PI3Kgþ /þ mice or vehicle-injected
PI3Kgþ /þ mice (Figure 9b). AQP2 was stained in the
apical membrane of the same tubules (Figure 9b). These
results demonstrated that phosphorylated Akt was localized
in the proximal tubules after the cisplatin injection.
Caspase-3 activity and cell death ELISA absorbance of
primary cultured TECs of PI3Kcþ /þ and PI3Kc/ mice with
or without cisplatin
To examine any further involvement of the PI3Kg–Akt path-
way in cisplatin-induced renal tubular injury, we cultured
the TECs of PI3Kgþ /þ and PI3Kg/ mice with primary
culture systems. As shown in Figure 10a, caspase-3 activity
began to increase at the tenth hour of the cisplatin
(50 mmol l1) treatment and then significantly increased with
increasing periods of treatment. Cisplatin increased caspase-3
activity dose dependently in TECs derived from both
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Figure 5 | Quantitative analysis of TNF-a and ICAM-1 mRNA expression and protein content in the renal tissues of PI3Kc/ and
PI3Kcþ /þ mice with cisplatin-induced acute kidney injury. (a) PI3Kgþ /þ and PI3Kg/ mice were administered 15 mg kg1 cisplatin
or vehicle, and then killed 12 h after the injection. Extracted total RNAs were subjected to quantitative PCR using the LightCycler Real-Time
PCR to estimate the TNF-a mRNA and ICAM-1 mRNA levels relative to the levels of GAPDH mRNA, as described in the Materials and
Methods section. Each column with a bar shows mean±s.e.m. (n¼ 6). (b) The representative agarose gels of PCR products for TNF-a,
ICAM-1, and GAPDH are shown. (c) PI3Kgþ /þ and PI3Kg/ mice were administered 15 mg kg1 of cisplatin or vehicle, and then killed
at 24 or 48 h after the injection. TNF-a was quantitated in extracted renal proteins by ELISA, as described in the Materials and Methods
section. Data are mean±s.e.m. of six mice per group. (d) PI3Kgþ /þ and PI3Kg/ mice were administered 15 mg kg1 cisplatin or
vehicle, and then killed at 24 or 48 h after the injection. ICAM-1 was quantitated in extracted renal proteins by ELISA, as described in the
Materials and Methods section. Data are mean±s.e.m. of six mice per group. NS, no significant difference between WT vs KO.
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PI3Kþ /þ and PI3Kg/ mice (Figure 10b). The TECs
from PI3Kg/ mice showed significantly higher caspase-3
activity than the TECs from PI3Kgþ /þ mice in the
presence of cisplatin. As shown in Figure 10c, absorbance
of cell death enzyme-linked immunosorbent assay (ELISA)
began to increase at the tenth hour of the cisplatin
(50 mmol l1) treatment and rose to significantly higher
levels as the treatment period continued. Cisplatin increased
the cell death ELISA absorbance dose dependently in the
TECs derived from both PI3Kþ /þ and PI3Kg/ mice
(Figure 10d). The TECs from PI3Kg/ mice showed signi-
ficantly higher cell death ELISA absorbance than the TECs
from PI3Kgþ /þ mice in the presence of cisplatin. These
results suggest that the PI3Kg–Akt pathway plays a protective
role in cisplatin-induced apoptosis in renal TECs.
Transfection of PI3Kc and dominant-active Akt using ade-
novirus prevents cisplatin-induced apoptosis in TECs from
PI3Kc/ mice
We further examined the antiapoptotic role of the PI3Kg–Akt
pathway in cisplatin-induced apoptosis in the TECs from
PI3Kg/ mice. We began by examining the efficiency
of adenovirus-mediated activation of Akt. The TECs from
PI3Kg/ mice were transfected for 48 h with PI3Kg
(AdPI3K), the dominant-active myristoylated form of Akt
(AdAkt), or a control adenovirus (Adnull) and then exami-
ned using phospho-specific Akt (Ser473) antibody to assess
protein expression. The phosphorylation of Akt was signi-
ficantly increased by transfection with PI3Kg (AdPI3K), the
dominant-active Akt (AdAkt) (Figure 11a). The phosphory-
lation of Akt was not observed in control adenovirus. The
TECs of PI3Kg/ mice were transfected for 48 h with
PI3Kg (AdPI3K), the dominant-active myristoylated form of
Akt (AdAkt), or a control adenovirus (Adnull) and then
exposed to cisplatin (50 mmol l1) for 24 h. The transfection
of PI3Kg or the active form of Akt reduced both the caspase-
3 activity and cell death ELISA absorbance, significantly and
by almost equal levels, in the TECs of PI3Kgþ /þ mice
(Figure 11b and d). The control adenovirus (Adnull) had no
effects on cisplatin-induced increments of caspase-3 activity
or cell death ELISA absorbance. We also performed western
blotting of cleaved caspase-3 in the presence of cisplatin with
or without transfection of PI3Kg or Akt in the TECs of
PI3Kg/ mice (Figure 11c). The band of cleaved caspase-3
was significantly increased by cisplatin treatment. The
transfection of PI3Kg or the dominant-active Akt reduced
the cleaved caspase-3 levels at significant and almost equal
levels in the TECs of PI3Kgþ /þ mice (Figure 11c).
Next, we examined the morphological changes induced by
cisplatin with or without transfection of PI3Kg or dominant-
active Akt by staining with annexin-V or propidium
iodide (PI) (Figure 12). Cisplatin treatment led to membrane
blebbing and positive staining for annexin-V (Figure 12b
and c). The transfection of PI3Kg or the active form of Akt
significantly reduced the number of annexin-V-positive TECs
in PI3Kgþ /þ mice (Figure 12e and f).
Ischemia/reperfusion stress and tunicamycin led to elevated
levels of BUN and serum creatinine in vivo, as well as
apoptotic change in TECs
Ischemia/reperfusion of bilateral renal arteries induced renal
dysfunction in PI3Kgþ /þ mice, increasing the BUN level
from 17.9±1.0 at baseline to 71.1±18.3 mg per 100 ml at 2
days after ischemia/reperfusion injury. The BUN level in
PI3Kg/ mice rose to as high as 138.9±41.7 mg per 100 ml
at 2 days, confirming that PI3Kg deficiency exacerbated
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Figure 6 | Phosphorylation of Akt and Bad in the renal tissues
of PI3Kcþ /þ and PI3Kc/ mice with cisplatin-induced acute
kidney injury. PI3Kgþ /þ and PI3Kg/ mice were administered
15 mg kg1 cisplatin or vehicle, and then killed at 24, 48, or 72 h after
the injection. Extracted renal proteins were examined by immunoblot
analyses for phosphorylated (Ser473) Akt, total Akt, phosphorylated
(Ser136) Bad, total Bad, and actin. Mice injected with vehicle at 0 h
served as controls. Extracted proteins (20mg) from the renal tissue
were separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis gels. Phosphorylated Akt, total Akt, phosphorylated
(Ser136) Bad, total Bad, and actin protein levels of PI3Kgþ /þ
mice kidneys (a) and PI3Kg/ mice kidneys (b) were detected by
western blot analysis. (c) Quantitative analyses of the levels of the
phosphorylated form of Akt vs the total Akt levels after the cisplatin
administration are shown for both PI3Kgþ /þ mice (white bar)
and PI3Kg/ mice (black bar). (d) Quantitative analyses of the levels
of the phosphorylated form of Bad vs the total Bad levels after
the cisplatin administration are shown for both PI3Kgþ /þ mice
(white bar) and PI3Kg/ mice (black bar). Data are mean±s.e.m.
of six mice per group. *Po0.05.
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ischemia/reperfusion-induced renal dysfunction (Figure 13a).
Serum creatinine levels increased from 0.21±0.10 to
1.31±0.43 mg per 100 ml at 2 days after ischemia/reperfusion
injury in PI3Kgþ /þ mice. The serum creatinine level in
PI3Kg/ mice increased from 0.20±0.10 to 2.42±0.78 mg
per 100 ml at 2 days, again indicating that PI3Kg deficiency
exacerbated ischemia/reperfusion-induced renal dysfunction
(Figure 13b). The difference between PI3Kgþ /þ and
PI3Kg/ mice, however, was not statistically significant.
Tunicamycin (0.20 mg kg1) treatment induced renal dys-
function in PI3Kgþ /þ mice increasing BUN and creatinine
levels from 18.1±1.1 to 60.8±17.8 mg per 100 ml and from
0.19±0.10 to 1.54±0.58 mg per 100 ml, respectively, at
3 days after the tunicamycin administration (Figure 13c
and d). PI3Kg deficiency in PI3Kg/ mice tended to exa-
cerbate tunicamycin-induced renal dysfunction, as shown in
Figure 13c and d. The difference between PI3Kgþ /þ and
PI3Kg/ mice, however, was not statistically significant.
We also performed in vitro experiments using TECs
derived from PI3Kþ /þ and PI3Kg/ mice under two
conditions, one in a hypoxic culture (10 h) and another in the
presence of tunicamycin (1 mmol ml1 for 36 h). Under the
hypoxic condition, caspase-3 activity and the values of cell
death ELISA were higher in the TECs from PI3Kg/ mice
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Figure 7 | Immunohistological examination of phosphorylated Akt (Ser473) in the renal tissues of PI3Kcþ /þ mice after the cisplatin
administration. (a) The renal cortex from PI3Kgþ /þ mice was immunostained with phosphorylated Akt (Ser473)- and AQP1-specific
antibodies. Positive staining of phosphorylated Akt was detected after the cisplatin injection (original magnification  100). (b) The renal
medulla from PI3Kgþ /þ mice was immunostained with phosphorylated Akt (Ser473)- and AQP1-specific antibodies. Positive staining of
phosphorylated Akt was detected in the outer medulla after the cisplatin injection (original magnification  100). IM, inner medulla; OM,
outer medulla; p-Akt, phosphorylated Akt; AQP1, aquaporin-1; Merge, merged condition.
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than in the TECs from PI3Kgþ /þ mice (Figure 13e). In the
presence of tunicamycin (1 mmol ml1), the caspase-3 activity
and cell death ELISA absorbance value were slightly higher
in the TECs from PI3Kg/ mice than in the TECs from
PI3Kgþ /þ mice (Figure 13f). The difference between the
TECs from PI3Kgþ /þ and PI3Kg/ mice, however, was
not statistically significant. These results suggest that the
PI3Kg–Akt pathway also may play a protective role in
hypoxia- and tunicamycin-induced apoptosis in renal TECs,
at least in vitro.
DISCUSSION
This study has produced three important findings: first, the
PI3K–Akt pathway is activated in cisplatin-induced AKI;
second, blockage of the PI3Kg–Akt pathway accelerates renal
tubular cell death and leads to poor prognoses; third, the
PI3Kg–Akt pathway mitigates apoptosis and plays a critical
role in the maintenance of renal function in cisplatin-induced
acute renal failure in vivo.
No previous studies have demonstrated that the inhibition
of the PI3Kg–Akt pathway accelerates renal tubular cell death
induced by cisplatin treatment. Cisplatin induces renal
tubular cell death both in vivo29 and in vitro.30,31 However,
studies have yet to identify the precise mechanism of the
apoptotic signal involving the PI3K–Akt pathway in cisplatin-
induced AKI. The mechanisms of cisplatin-induced cell death
of renal tubular cells have been investigated mainly in in vitro
studies. Cisplatin-induced cell death in LLC-PK1 cells is
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Figure 8 | Immunohistological examination of phosphorylated Akt (Ser473) in the renal tissues of PI3Kc/ mice after the cisplatin
administration. (a) The renal cortex from PI3Kg/ mice was immunostained with phosphorylated Akt (Ser473)- and AQP1-specific
antibodies. Staining of phosphorylated Akt was not detected after the cisplatin injection or vehicle injection (original magnification  100).
(b) The renal medulla from PI3Kg/ mice was immunostained with phosphorylated Akt (Ser473)- and AQP1-specific antibodies (original
magnification  100). IM, inner medulla; OM, outer medulla; p-Akt, phosphorylated Akt; AQP1, aquaporin-1; Merge, merged condition.
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caused via activation of mitochondrial signaling pathways
and independent pathways.11,12 An in vivo study by Ramesh
and Reeves6,7 showed that TNF-a contributes to renal injury
and AKI after the cisplatin administration. The cisplatin
administration in their experiments upregulated several
cytokines, including TNF-a, and their TNF-a-deficient
mice were resistant to cisplatin-induced nephrotoxicity. The
apoptotic signal of TNF-a begins from the cell death receptor
and proceeds to the activation of procaspase-8, whereupon
the activated procaspase-8 cleaves and activates procaspase-3.
A number of studies have recently demonstrated that
the PI3K–Akt pathway inhibits these apoptotic pathways
in vitro.26–28 The PI3K–Akt pathway mediates antiapoptotic
signals by inhibiting caspase-9 in HepG6 cells and stimulat-
ing the nuclear factor-kB pathway in COS cells.32–35 PI3K has
been reported to activate SGK1 (serum- and glucocorticoid-
inducible kinase 1).36 SGK1 confers cell survival via
phosphorylation of forkhead transcription factors such as
FKRHL1.36 Thus, several pathways downstream of PI3K may
contribute.
Bad is a proapoptotic member of the Bcl-2 family that can
displace Bax from binding to Bcl-2 and Bcl-xL and can cause
cell death. Akt pathway has been reported to inhibit the
apoptotic activity of Bad by inducing Ser136 phosphorylation.37
p-Akt
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Figure 9 | Immunohistological examination of phosphorylated Akt (Ser473) in the renal tissues of PI3Kcþ /þ mice after the cisplatin
administration, at high-power magnification. (a) The renal outer medulla taken from PI3Kgþ /þ mice after the cisplatin injection was
immunostained with phosphorylated Akt (Ser473)- and AQP1-specific antibodies. Positive staining of phosphorylated Akt was detected after
the cisplatin injection (original magnification  600). The renal outer medulla taken from PI3Kgþ /þ mice after injection of vehicle was
immunostained with phosphorylated Akt (Ser473)- and AQP1-specific antibodies (original magnification  600). p-Akt, phosphorylated
Akt; AQP1, aquaporin-1; Merge, merged condition. (b) The renal cortex taken from PI3Kgþ /þ mice after the cisplatin injection was
immunostained with phosphorylated Akt (Ser473)- and AQP2-specific antibodies (original magnification  600). The renal cortex taken
from PI3Kgþ /þ mice after injection of vehicle was immunostained with phosphorylated Akt (Ser473)- and AQP2-specific antibodies
(original magnification  600). p-Akt, phosphorylated Akt; AQP2, aquaporin-2; Merge, merged condition.
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Phosphorylation of Ser136 results in the binding of Bad to
14-3-3 proteins and the inhibition of Bad binding to Bcl-2
and Bcl-xL. We demonstrated that the phosphorylation of
Bad (Ser136) was induced after the cisplatin injection in
wild-type mice and that it was significantly reduced in
PI3Kg/ mice. Thus, our data suggested that Bcl-2 proteins
such as Bad may play a role in cisplatin-induced renal tubular
apoptosis in the downstream of Akt. Recent reports have
revealed the crosstalk between the PI3K–Akt pathway and the
tumor suppressor p53.38 The latter activates the transcription
of PTEN (phosphatase with tensin homology) and therefore
functions as a negative regulator of the PI3K signaling path-
way. Downregulation of the PI3K signaling pathway by p53
activation is further enforced through p53-mediated trans-
criptional repression of the gene encoding the p110 subunit
of PI3K. Recently, Kim et al.39 have reported that the activa-
tion of the PI3K signaling pathway via a mutation in PTEN
or p110 subunit of PI3K activates p53 signaling in human
cells. Another example of intermolecular crosstalk exists
in the recently documented interaction between p53 and
FOXO3A, which is a substrate of Akt. p53 regulates the
expulsion of FOXO3A from the nucleus in response to DNA
damage. The investigation of p53 pathway in PI3Kg–/– mice
is a very interesting topic, and this pathway should be further
studied in future. However, whether these pathways play
antiapoptotic roles in the renal tubular cells remains open to
question. The significant increase in apoptotic renal tubular
cells induced by the cisplatin treatment in PI3Kg/ mice in
our in vivo experiments and the finding from our experi-
ments using primary cultured TECs from PI3Kg/ mice
in vitro clearly demonstrate that the PI3Kg–Akt pathway plays
an antiapoptotic role in cisplatin-induced AKI.
Our study is also the first to reveal that cisplatin treatment
phosphorylates Akt in renal tubular cells in vivo. The phos-
phorylation of Akt is observed from 24 h after the cisplatin
treatment and peaks at 48 h. The Akt activation was observed
somewhat later than the cisplatin-induced production of
TNF-a and ICAM-1. An earlier report has demonstrated that
TNF-a and ICAM-1 may stimulate the PI3K–Akt pathway
in renal tubules.40 Our findings, in contrast, fall short of
identifying the cytokines or signals that stimulate the
PI3K–Akt pathway in cisplatin-treated renal tubules. Further
studies will therefore be necessary to identify the mechanisms
behind the cisplatin-induced activation of the PI3K–Akt
pathway in the renal tissue. In vitro experiments by Kaushal
et al.12 using LLC-PK1 cells subjected to cisplatin injury
revealed that cisplatin activates Akt phosphorylation, and
further that the Akt phosphorylation so activated regulates
the mitochondrial-dependent activation of caspase-9 and
caspase-3. These findings on the cisplatin-induced activation
of Akt in our study and studies by other groups suggest that
an activated PI3K–Akt pathway could play an antiapoptotic
role in cisplatin-induced AKI. The findings from our study
also demonstrated that the transfection of PI3Kg and the
dominant-active form of Akt using an adenovirus preserves
the cisplatin-induced apoptosis of primary cultured TECs
from PI3Kg/ mice. The effects of cisplatin treatment in
activating caspase-3 activity and increasing the value of the
cell death ELISA assay are more potent in the TECs from
PI3Kg/ mice than in the TECs from PI3Kgþ /þ mice.
The gene transfer of PI3Kg or the dominant-active form of
Akt reduces the cisplatin-induced caspase-3 activity and the
value of the cell death ELISA assay in the TECs of PI3Kg/
mice to the levels similar to those of the TECs of PI3Kgþ /þ
mice. These results strongly suggest that the activation of the
PI3Kg–Akt pathway prevents the cisplatin-induced apoptosis
of renal tubules and ameliorates renal toxicity.
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Figure 10 | Caspase-3 activity assay and cell death ELISA assay
of primary cultured TECs of PI3Kcþ /þ and PI3Kc/ mice with
or without the cisplatin administration. (a) Caspase-3 enzymatic
activity was measured colorimetrically by the procedure described in
the Materials and Methods section. Caspase-3 activity was measured
in the TECs from PI3Kgþ /þ mice (K) and PI3Kg/ mice (’)
at indicated times of cisplatin (50 mmol l1) treatment. Data are
mean±s.e.m. of six experiments per group. *Po0.05, WT vs KO.
(b) The TECs from PI3Kgþ /þ mice (white bar) and PI3Kg/ mice
(black bar) were treated with the indicated dose of cisplatin for 25 h.
Cisplatin increased caspase-3 activity dose dependently. The TECs
from PI3Kg/ mice (black bar) show higher caspase-3 activity than
the TECs from PI3Kgþ /þ mice (white bar). Data are mean±s.e.m.
of six experiments per group. *Po0.05, WT vs KO. (c) Cell death
detection ELISA assays were measured in the TECs from PI3Kgþ /þ
mice (K) and PI3Kg/ mice (’) at indicated times of cisplatin
(50mmol l1) treatment. Data are mean±s.e.m. of six experiments
per group. *Po0.05, WT vs KO. (d) The TECs from PI3Kg/ mice
(black bar) and PI3Kgþ /þ mice (white bar) were treated with the
indicated dose of cisplatin for 25 h. Cisplatin increased cell death
ELISA absorbance dose dependently. The TECs from PI3Kg/ mice
(black bar) show higher absorbance than the TECs from PI3Kgþ /þ
mice (white bar). Data are mean±s.e.m. of six experiments per
group. *Po0.05, WT vs KO.
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The results from this study also show that PI3Kg defi-
ciency will worsen the prognosis of cisplatin-induced AKI.
The direct effects of a PI3Kg gene deletion on renal function
are not well known. Under control conditions, however,
no abnormalities are reported in the renal function or
histology.22,23 The changes in renal function and prognosis
induced by the PI3Kg deletion here may result from one of
the three possible mechanisms. First, the deletion may have
a direct effect on the apoptotic pathway in renal tubular cells.
Second, the cytokines induced by cisplatin, such as TNF-a
and ICAM-1, may be increased in PI3Kg/ mice. Third,
impaired T-cell function may cause renal damage in PI3Kg/
mice. In this study, we compared the mRNA and protein
levels of TNF-a and ICAM-1 in PI3Kg/ and PI3Kgþ /þ
mice after the cisplatin administration. As shown in Figure 5,
there was no significant difference in the mRNA or protein
levels between the two mouse groups. We also counted the
infiltrated leukocytes in PI3Kg/ and PI3Kgþ /þ mice
after the cisplatin administration. As shown in Figure 3, the
infiltrated leukocytes were more abundant in PI3Kg/
mice than in PI3Kgþ /þ mice. Previous studies reported
that T-cell migration is impaired in PI3Kg/ mice,23 and
that blockage of PI3Kg suppresses joint inflammation and
damage in mouse models of rheumatoid arthritis and other
types of inflammation.41,42 The data on the increments of
infiltrated leukocytes in PI3Kg/ mice in our study may
reflect the severity of histological renal damage more closely
than the migratory function of T cells. In the light of this, we
prefer the first of the three potential mechanisms mentioned
earlier, namely, that the apoptosis itself caused the renal
damage and poor prognosis in PI3Kg/ mice. Our study
demonstrated that the renal tubular cells from PI3Kg/
mice are too sensitive to succumb to apoptosis when exposed
to cisplatin either in vivo or in vitro, and that apoptosis is
restored by transfection of PI3Kg and dominant-active Akt
in vitro. Recent studies have demonstrated that the inhibition
of apoptosis ameliorates acute renal failure in several murine
models. Caspase-1 was revealed to contribute to apoptosis in
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Figure 11 | Transfection of PI3Kc and the dominant-active form of Akt prevents the cisplatin-induced caspase-3 activity and cell death
ELISA activity of the TECs derived from PI3Kc/ mice. (a) The phosphorylation of Akt was significantly increased by transfection with
PI3Kg (AdPI3K), the dominant-active Akt (AdAkt). The phosphorylation of Akt was not observed in control adenovirus. (b) Caspase-3 enzymatic
activity was measured colorimetrically by the procedure described in the Materials and Methods. The TECs from PI3Kg/ mice were
transfected with AdPI3K, AdAkt, or Adnull for 48 h, and then treated with 50 mmol l1 cisplatin for 24 h. Transfection of either AdPI3K or
AdAkt significantly reduced the cisplatin induced-caspase-3 activity of the TECs from PI3Kg/ mice. These values were almost equal to the
level of TECs derived from PI3Kgþ /þ mice (white bar). Data are mean±s.e.m. of six experiments per group. *Po0.05. (c) We also performed
western blotting of cleaved caspase-3 in the presence of cisplatin with or without the transfection of PI3Kg or Akt in the TECs of PI3Kg/
and PI3Kg/ mice. (d) Cell death detection ELISA assays were performed by the procedure described in the Materials and Methods section.
The TECs from PI3Kg/ mice were transfected with AdPI3K, AdAkt, or Adnull for 48 h, and then treated with 50 mmol l1 cisplatin for
25 h. Transfection of either AdPI3K or AdAkt significantly reduced the cisplatin induced-cell death ELISA absorbance of the TECs from
PI3Kg/ mice. These values were almost equal to the levels of TECs derived from PI3Kgþ /þ mice (white bar). Data are mean±s.e.m.
of six experiments per group. *Po0.05.
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cisplatin-induced AKI in experiments with caspase-1-defi-
cient mice.43 Deficiencies of proapoptotic genes such as
PARP (poly ADP-ribose polymerase) and thrombospondin-1
ameliorate ischemia-induced AKI.44,45 Furthermore, inhibi-
tion of apoptosis by a caspase inactivator (ZVAD-fmk)
prevents ischemia-induced renal tissue injury, including
inflammation.14 Thus, the apoptotic process in renal cells is
likely to promote the renal functional damage and histolo-
gical damage of AKI. Our data strongly support the notion
that the antiapoptotic PI3Kg–Akt pathway confers strong
protection against the renal damage induced by cisplatin. We
also conducted experiments to examine how the TECs from
PI3Kg/ and PI3Kg/ mice responded to other stresses,
namely, ischemia/reperfusion and stress to the endoplasmic
reticulum (by tunicamycin).46 As demonstrated in Figure 13,
PI3Kg/ mice were more susceptible to ischemia/reperfu-
sion injury. When PI3Kg/ mice were subjected to
tunicamycin-induced renal injury, the renal dysfunction
tended to be exacerbated. However, the difference of renal
function between PI3Kgþ /þ and PI3Kg/ mice was not
statistically significant. The TECs from PI3Kg/ mice in
the in vitro experiments showed higher caspase-3 activity and
greater cell death ELISA absorbance than the TECs from
PI3Kgþ /þ mice under hypoxic stress and in the presence of
tunicamycin. These results suggest that the PI3Kg–Akt
pathway also protects against several kinds of stresses.
Now that many subtypes of PI3K have been reported,
future studies to examine the involvement of other PI3Ks
in renal function should be planned. Yet PI3Ka/ and
PI3Kb/ mice showed early-stage lethality during embryo-
nic development,20,21 and the knockout mouse of the
PI3Kp85a regulatory subunit manifested increased insulin
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sensitivity and hypoglycemia resulting from increased glucose
transport.47 Thus, conditional knockout techniques of
these mice may be necessary to examine the involvement of
PI3Ka, PI3Kb, and PI3Kp85a genes in the renal patho-
physiology. Mice lacking expression of PI3Kp110d exhibited
impairment in B- and T-cell activation, as well as in mast
cell activation.48,49 The functional role of PI3Kp110d in renal
pathophysiology is another interesting theme for future
study.
In conclusion, this study produced three important
findings: first, the PI3K–Akt pathway is activated in
cisplatin-induced AKI; second, blockage of the PI3Kg–Akt
pathway worsens the prognosis by accelerating renal tubular
cell death; third, the PI3K–Akt pathway mitigates apoptosis
and plays a critical role in the maintenance renal function in
cisplatin-induced acute renal failure in vivo. These data
support the notion that antiapoptotic pathways such as
PI3K–Akt provide a potential target for therapeutic inter-
vention for AKI.
MATERIALS AND METHODS
Animals and drug administration
Experiments were performed on 8- to 10-week-old male C57BL/6
mice or PI3Kg/ mice weighing 20–25 g.22,23 These mice had been
well characterized before the outset of this study by our group and
no abnormalities had been reported in either their renal function or
histology.22,23 C57BL/6 male mice with the same background were
obtained from the Jackson Laboratories (Yokohama, Japan) for use
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Figure 13 | Blood urea nitrogen (BUN) and serum creatinine (Cre) levels after ischemia/reperfusion renal injury or injection of
tunicamycin in PI3Kcþ /þ and PI3Kc/ mice. Blood was collected at 0 (control), 1, and 2 days after the ischemia/reperfusion renal injury
in PI3Kgþ /þ mice (white bar) and PI3Kg/ mice (black bar) (N¼ 6, each group). BUN (a) and serum creatinine (b) were measured. Blood
was collected at 0 (control), 2, and 3 days after tunicamycin injection in PI3Kgþ /þ mice (white bar) and PI3Kg/ mice (black bar) (N¼ 6,
each group). BUN (c) and serum creatinine (d) were measured. Data are mean±s.e.m. of six mice per group. Caspase-3 enzymatic activity
and cell death ELISA were measured by the procedure described in the Materials and Methods section (e). The TECs from PI3Kg/ mice
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for caspase-3 enzymatic activity and cell death ELISA (f). Data are mean±s.e.m. of six experiments per group.
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as wild-type controls. The mice were maintained on a standard diet
with free access to water. Cisplatin (Sigma-Aldrich, St Louis, MI,
USA) was dissolved in saline at a concentration of 1 mg ml1. The
mice were given a single intraperitoneal injection of either a vehicle
(saline) or cisplatin (15, 20, or 30 mg per kg body weight). The
ischemia/reperfusion models were prepared by clamping bilateral
renal pedicles with surgical clips (Mizuho, Tokyo, Japan) and
visually inspecting the kidneys to confirm the occlusion of blood
flow. The clamps were left in place for 25 min and then released.
Each animal was given a single intraperitoneal injection of either
vehicle (saline) or tunicamycin (20 mg per kg body weight). Blood
was obtained via retro-orbital bleeding immediately before the
injection and at various time points after the injection for the
measurement of BUN and serum creatinine. The animals were killed
at different time intervals and the tissue was processed for histology
and protein and RNA isolation. BUN and serum creatinine were
measured using a commercially available kit (Sigma-Aldrich).50
Animal care followed the criteria of the Tokyo Medical and Dental
University for the care and use of laboratory animals in research
(approval no. 14298).
Histology and immunohistochemistry
Kidney tissue was embedded in paraffin wax and 5 mm sections were
stained with a hematoxylin–eosin staining kit (kit no. 91A; Sigma-
Aldrich). Tubular injury was assessed using a semiquantitative
scale.6,50 Histological changes due to tubular necrosis were
quantitated by counting the percent of tubules with evident cell
necrosis, loss of brush border, cast formations, and tubule dilatation
as follows: 0¼ none, 1¼p10%, 2¼ 11–25%, 3¼ 26–45%,
4¼ 46–75%, and 5¼X76%. At least 5–10 fields ( 200) were
reviewed for each slide. Leukocyte infiltration was measured by
naphthol AS-D chloroacetate esterase staining.6 Positively stained
cells were counted in 10 random areas in the cortex and 10 random
areas in the outer medulla by a blind observer.
For immunohistochemical studies, kidneys were perfused in vitro
with 4% paraformaldehyde in a phosphate buffer, removed, and
immersed overnight in the same fixative at 4 1C. The fixed tissue was
cryoprotected by immersion in 20% sucrose in phosphate-buffered
saline at 4 1C and then shock-frozen in liquid nitrogen.51 The
primary antibodies included an anti-phospho Akt-specific antibody
(Transduction Laboratories, San Jose, CA, USA). An anti-rabbit IgG
FITC-conjugated antibody (Sigma, St Louis, MI, USA) was used as
the secondary antibody for the anti-phospho Akt. The slides were
mounted and examined under a confocal laser microscope (Carl
Zeiss Japan, Tokyo, Japan).
TUNEL staining (in situ detection of DNA fragmentation)
The in situ DNA strand breaks were detected by the TUNEL method
using a TACS2 TdT-blue label in situ apoptosis detection kit
(Trevigen Inc., Gaithersburg, MD, USA). Paraffin sections were
deparaffinized, rehydrated, and incubated with proteinase K, an
endogenous cation, and the TdT enzyme. The sections were stained
with the blue label after treatment with streptavidin–horseradish
peroxidase. The TUNEL-positive cells in the tubules were counted in
10 random areas in the cortex and 10 random areas in the medulla
by a blind observer.
Real-time quantitative PCR
We performed reverse transcription and a real-time quantitative
PCR for TNF-a and ICAM-1 from RNA extracted from the kidneys,
as described previously.52 The RNA was extracted from the renal
tissue using TRI-REAGENT (Life Technologies, Gaithersburg, MD,
USA). TNF-a primer 1 (antisense) encompassed bases 242–261 and
primer 2 (sense) encompassed bases 32–50 (GenBank no. M38296).
The sequence of primer 1 was 50-AGGGTCTGGGCCATAGAACT-30
and that of primer 2 was 50-GAACTGGCAGAAGAGGCACT-30. The
predominant cDNA amplification product was predicted to be
230 bp in length. ICAM-1 primer 1 (antisense) encompassed bases
784–803 and primer 2 (sense) encompassed bases 533–522 (GenBank
no. M31585). The sequence of primer 1 was 50-CTTCAGAGGCAGG
AAACAGG-30 and that of primer 2 was 50-AGATCACATTCA
CGGTGCTG-30. The predominant cDNA amplification product was
predicted to be 252 bp in length. Data for positive control were
provided by real-time quantitative PCR of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH).52 The primers were defined
by the following cDNA base sequences: primer 1 (antisense), bases
795–814, sequence, 50-AGATCCACAACGGATACATT-30; primer 2
(sense), bases 506–525, sequence, 50-TCCCTC AAGATTGTCAGC
AA-30. The predominant cDNA amplification product was predicted
to be 309 bp in length. PCR products were detected and quantitated
in real time using the LightCycler Real-time PCR system (Roche
Molecular Biochemicals, Tokyo, USA), as described previously.53,54
Quantitation of protein levels of TNF-a and ICAM-1 by ELISA
The protein levels of TNF-a and ICAM-1 in mouse kidney tissue
were measured using commercially available cytokine-specific
murine ELISA kits (Quantikine Mouse TNF-a and Quantikine
Mouse ICAM-1 kits; R&D System, Minneapolis, MN, USA)
according to the manufacturer’s directions. Kidney tissue was
homogenized in phosphate-buffered saline containing 0.05% Tween
20, and aliquots containing 300 mg of total protein were used for the
TNF-a and ICAM-1 protein assay.
Primary culture of mouse renal TECs
Primary mouse renal TECs were generated by the method of
Wuthrich et al.55 Briefly, the renal capsules were removed from four
PI3Kg/ mice and four PI3Kgþ /þ mice, and then the tissue
from the cortex was cut into approximately 1 mm3 pieces. Single
cortical tubule suspensions were prepared from freshly dissected
kidney cortex from mice of each genotype by collagenase type 1A
(Sigma-Aldrich) dispersion at 37 1C for 1 h and washed in RPMI
1640 medium (Gibco BRL; Invitrogen Corp., Rockville, MD, USA).
The TECs were subsequently grown in duplicate to confluence on
six-well plates for 10 days in RPMI 1640 medium supplemented
with 10% fetal calf serum (Gibco BRL, Carlsbad, CA, USA); 2 mM
L-glutamine, 100 IU ml1 penicillin, and 50 mg ml1 streptomycin
(all from Invitrogen Corp.). The TECs were identified by their
characteristic polygonal or cobblestone-shaped morphology. After
an initial incubation until 80% confluence, the cells were treated
with a medium with serum. The cisplatin or tunicamycin was added
to the medium at indicated concentrations and at indicated times.
For the hypoxia experiments, the cells were placed in a hypoxic
chamber (Bellow Glass Inc., Vineland, NJ, USA) containing 0% O2
and 5% CO2, maintained at 37 1C.
50 The cells were collected and
subjected to caspase-3 activity assay and cell death ELISA assay by
the method previously reported.56,57
Western blot analysis. Homogenized total renal tissues were
lysed in an sodium dodecyl sulfate sample buffer (50 mM HEPES
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) pH 7.5, 150 mM
NaCl, 1.5 mM MgCl2, 1 mM EGTA (ethylene glycol bis(b-aminoethyl-
ether)-N,N,N’,N’,-tetraacetic acid), 10% glycerol, 1% Triton X-100,
1mg ml1 aprotinin, 1mg ml1 leupeptin, 1 mM phenylmethylsulfonyl
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fluoride, and 0.1 mM sodium orthovanadate) at 4 1C.58 Protein was
transferred to a nitrocellulose membrane and probed with poly-
clonal antibodies against Akt, phospho (Ser473)-specific Akt, Bad,
phospho (Ser136)-specific Bad, and actin (Cell Signaling Biotechno-
logy, Beverly, MA, USA). The primary antibodies were detected
using horseradish peroxidase-conjugated rabbit anti-mouse IgG and
visualized by the Amersham ECL system (Amersham Corp., Arlington
Heights, IL, USA). The band intensities were quantitated using
Molecular Dynamic ImageQuant Software (Sunnyvale, CA, USA).
Adenoviruses. A previously described method was used to
prepare replication-defective, recombinant adenoviruses encoding
a wild-type PI3Kg (AdPI3K) and dominant-active myristoylated Akt
(AdAkt), as well as the control adenovirus vector (Adnull).59 Each
adenovirus preparation was titrated by a plaque assay on 293 cells.
Viral stocks (1 1010 to 1 1011 plaque-forming units (pfu) ml1)
were stored at 80 1C and thawed on ice just before use.
Caspase-3 assays. A Caspase-3 Fluorometric Protease Assay
kit (MBL, Tokyo, Japan) was used for the measurement of caspase-3
activities by a previously described method.59 In brief, the TECs
were plated in six-well dishes, infected with adenoviruses for 48 h
and exposed to indicated concentrations of cisplatin. The cell lysates
were then incubated with the same amounts of a reaction buffer
and a 50 mM DEVD-AFC substrate for 2 h at 37 1C. Fluorescence was
monitored at an excitation wavelength of 400 nm and an emission
wavelength of 505 nm.
Cell death ELISA. Histone-associated DNA fragments were
quantitated by ELISA (Boehringer Mannheim, Tokyo, Japan). In
brief, the TECs were plated in six-well dishes and infected with
adenoviruses for 48 h. The cells were exposed to indicated
concentrations of cisplatin. All cells from each well were collected
by trypsinization and pipetting, and then pelleted (800 r.p.m.,
5 min), lysed, and subjected to ELISA capture according to the
manufacturer’s protocol.59 Cytosolic proteins were collected using a
cell lysis buffer and centrifuged according to the protocol of each
manufacturer, and then the cytoplasmic fractions were collected for
the ELISA assay. Each experiment was carried out in triplicate and
repeated in at least five independent experiments.
Annexin-V FITC/PI staining. TECs were stained with annexin
V/PI and observed under a fluorescence microscope in multiple
experiments. The assay relies on two factors: first, the ability of
annexin-V (green fluorescence) to bind to the phosphatidylserine
exposed on the surface of cells undergoing apoptosis; second, the
ability of PI (red fluorescence) to enter cells that have lost their
membrane integrity. TECs were grown on chamber slides and
incubated in the dark for 5 min at room temperature with 200 ml of
one binding buffer, 1 ml of FITC-labeled recombinant annexin-V,
and 1 ml of PI. The cells were observed and counted (300 cells for
each condition and experiment) under a fluorescence microscope
using a dual filter set for FITC and rhodamine. Cells that lost
membrane integrity showed red staining throughout the nucleus
and a halo of green staining on the cell surface. The apoptotic
phenomena were evaluated based on the percentages of cells stained
positively for annexin-V and negatively for PI.
Statistics
The results are given as means±s.e.m. For single comparisons,
normally distributed data were evaluated using unpaired, two-tailed
Student t-tests and non-normally distributed data were analyzed by
the nonparametric unpaired Mann–Whitney test. Multiple group
comparisons were performed using analysis of variance (ANOVA)
with post-testing according to Newman–Keuls. Survival studies were
analyzed by using the Kaplan–Meier method and compared them
using the log-rank test. A P-value of o0.05 was considered
statistically significant.
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